US commercial payers expect the Institute for Clinical and Economic Review’s efforts to update its cost effectiveness assessments using real world evidence could be the most impactful of the changes to its methodology implemented this year, according to a recently-released survey by contract research organization ICON.
The survey of 30 payers explored several aspects of ICER’s cost effectiveness methodology update for 2020-2023, which was released early this year